BlossomHill Therapeutics, Inc.
BLSM
$16.18
-$0.17-1.04%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.21M | 1.88M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.11M | 11.45M | |||
| Operating Income | -22.11M | -11.45M | |||
| Income Before Tax | -21.01M | -10.48M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.01M | -10.48M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.01M | -10.48M | |||
| EBIT | -22.11M | -11.45M | |||
| EBITDA | -21.98M | -11.37M | |||
| EPS Basic | -8.14 | -4.39 | |||
| Normalized Basic EPS | -5.09 | -2.74 | |||
| EPS Diluted | -8.14 | -4.39 | |||
| Normalized Diluted EPS | -5.09 | -2.74 | |||
| Average Basic Shares Outstanding | 2.58M | 2.39M | |||
| Average Diluted Shares Outstanding | 2.58M | 2.39M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||